Explore trending stories, in-depth articles, and exclusive updates at AmeriPharmTimes
Risdiplam (Evrysdi): A High-Profile Drug for Treating Spinal Muscular Atrophy (SMA) Introduction Spinal muscular atrophy (SMA) is a rare genetic disorder that affects approximately one in 6,000 to 10,000 live births globally, causing progressive muscle weakness and atrophy. SMA is caused by mutations in the SMN1 gene, responsible for producing the survival motor neuron (SMN)…
Episil (Episil-1): A Novel Drug Gaining Significant Interest Introduction In the evolving landscape of pharmaceuticals, advancements in drug delivery systems have taken center stage. One such novel innovation that has garnered significant attention in recent years is Episil (Episil-1). Primarily aimed at providing relief for patients suffering from oral mucositis, Episil represents a breakthrough in…
Top 10 Novel Drugs Introduction The pharmaceutical industry is in a constant state of flux, with new drug developments promising to reshape the landscape of medical treatments. As we look towards the future, several novel drugs are poised to make significant impacts on the US market. This article highlights the top 10 novel drugs currently…